Interstitial lung disease and pulmonary fibrosis in hermansky-pudlak syndrome type 2, an adaptor protein-3 complex disease

Bernadette R. Gochuico, Marjan Huizing, Gretchen A. Golas, Charles D. Scher, Maria Tsokos, Stacey D. Denver, Melissa J. Frei-Jones, William A. Gahl

Research output: Contribution to journalArticle

48 Scopus citations

Abstract

Pulmonary fibrosis develops in Hermansky-Pudlak syndrome (HPS) types 1 and 4. Limited information is available about lung disease in HPS type 2 (HPS-2), which is characterized by abnormal function of the adaptor protein-3 (AP-3) complex. To define lung disease in HPS-2, one child and two adults with HPS-2 were evaluated at the National Institutes of Health on at least two visits, and another child was evaluated at the University of Texas Health Science Center San Antonio. All four subjects with HPS-2 had findings of interstitial lung disease (ILD) on a high-resolution computed tomography scan of the chest. The predominant feature was ground glass opacification. Subject 1, a 14-year-old male, and subject 4, a 4-year-old male, had severe ILD, pulmonary fibrosis, secondary pulmonary hypertension and recurrent lung infections. Lung biopsy performed at 20 months of age in subject 1 revealed interstitial fibrosis and prominent type II pneumocyte hyperplasia without lamellar body enlargement. Subject 2, a 27-year-old male smoker, had mild ILD. Subject 3, a 22-year-old male nonsmoker and brother of subject 2, had minimal ILD. Severe impairment of gas exchange was found in subjects 1 and 4 and not in subjects 2 or 3. Plasma concentrations of transforming growth factor-β1 and interleukin-17A correlated with severity of HPS-2 ILD. These data show that children and young adults with HPS-2 and functional defects of the AP-3 complex are at risk for ILD and pulmonary fibrosis.

Original languageEnglish (US)
Pages (from-to)56-64
Number of pages9
JournalMolecular Medicine
Volume18
Issue number1
DOIs
Publication statusPublished - Jan 1 2012

    Fingerprint

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Gochuico, B. R., Huizing, M., Golas, G. A., Scher, C. D., Tsokos, M., Denver, S. D., ... Gahl, W. A. (2012). Interstitial lung disease and pulmonary fibrosis in hermansky-pudlak syndrome type 2, an adaptor protein-3 complex disease. Molecular Medicine, 18(1), 56-64. https://doi.org/10.2119/molmed.2011.00198